T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Kemper
KMPR
$1.59B
| $7.31M | ﹤0.01% |
113,310
+37,027
| +49% | +$2.29M |
|
|
RERE
1177
ATRenew
RERE
$1.02B
| $7.3M | ﹤0.01% |
2,205,233
-33,801
| -2% | -$87.9K |
|
1178
Omega Healthcare
OHI
$13.9B
| $7.29M | ﹤0.01% |
198,822
+13,078
| +7% | +$486K |
|
1179
AptarGroup
ATR
$8.43B
| $7.29M | ﹤0.01% |
46,574
+1,380
| +3% | +$208K |
|
|
DAWN
1180
DELISTED
Day One Biopharmaceuticals
DAWN
| $7.29M | ﹤0.01% |
1,120,631
-52,463
| -4% | -$361K |
|
1181
Regal Rexnord
RRX
$11.4B
| $7.28M | ﹤0.01% |
50,219
+667
| +1% | +$83.7K |
|
1182
MediWound
MDWD
$174M
| $7.26M | ﹤0.01% |
374,871
+215,180
| +135% | +$4.05M |
|
1183
Phinia Inc
PHIN
$2.7B
| $7.2M | ﹤0.01% |
161,831
+12,258
| +8% | +$517K |
|
1184
GameStop
GME
$8.33B
| $7.18M | ﹤0.01% |
294,240
+11,539
| +4% | +$309K |
|
1185
Virtus Investment Partners
VRTS
$1.14B
| $7.12M | ﹤0.01% |
39,250
-28,821
| -42% | -$4.8M |
|
|
HAPN
1186
Happen Inc
HAPN
$2.27B
| $7.09M | ﹤0.01% |
589,371
-80,328
| -12% | -$834K |
|
1187
Sana Biotechnology
SANA
$1.1B
| $6.98M | ﹤0.01% |
2,557,825
-96,313
| -4% | -$199K |
|
1188
Birkenstock
BIRK
$7.54B
| $6.98M | ﹤0.01% |
141,922
+20,859
| +17% | +$1.07M |
|
|
SKX
1189
DELISTED
Skechers
SKX
| $6.95M | ﹤0.01% |
110,087
-118,345
| -52% | -$6.8M |
|
|
QXO
1190
QXO Inc
QXO
$16.1B
| $6.9M | ﹤0.01% |
320,214
+236,386
| +282% | +$3.88M |
|
1191
American Financial Group
AFG
$12.1B
| $6.85M | ﹤0.01% |
54,282
-10,250
| -16% | -$1.28M |
|
1192
Houlihan Lokey
HLI
$9.24B
| $6.84M | ﹤0.01% |
38,006
+2,032
| +6% | +$341K |
|
1193
NorthWestern Energy
NWE
$4.4B
| $6.84M | ﹤0.01% |
133,291
+20,631
| +18% | +$1.14M |
|
1194
Alector
ALEC
$228M
| $6.83M | ﹤0.01% |
4,875,264
+4,198,951
| +621% | +$5.26M |
|
1195
New York Times
NYT
$10.3B
| $6.82M | ﹤0.01% |
121,834
+2,654
| +2% | +$141K |
|
1196
Avantor
AVTR
$9.37B
| $6.82M | ﹤0.01% |
506,372
+14,077
| +3% | +$193K |
|
1197
Kratos Defense & Security Solutions
KTOS
$11.8B
| $6.75M | ﹤0.01% |
145,213
+16,701
| +13% | +$605K |
|
1198
California Water Service
CWT
$3.1B
| $6.74M | ﹤0.01% |
148,154
+89,847
| +154% | +$4.3M |
|
1199
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $6.71M | ﹤0.01% |
60,723
+1,168
| +2% | +$121K |
|
|
FLG
1200
Flagstar Bank National Association
FLG
$5.92B
| $6.64M | ﹤0.01% |
626,762
+42,547
| +7% | +$486K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.